BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9000668)

  • 1. Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase.
    Hoffman RA; Nüssler NC; Gleixner SL; Zhang G; Ford HR; Langrehr JM; Demetris AJ; Simmons RL
    Transplantation; 1997 Jan; 63(1):94-100. PubMed ID: 9000668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bystander injury of host lymphoid tissue during murine graft-verus-host disease is mediated by nitric oxide.
    Hoffman RA; Langrehr JM; Berry LM; White DA; Schattenfroh NC; McCarthy SA; Simmons RL
    Transplantation; 1996 Feb; 61(4):610-8. PubMed ID: 8610389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation.
    Drobyski WR; Keever CA; Hanson GA; McAuliffe T; Griffith OW
    Blood; 1994 Oct; 84(7):2363-73. PubMed ID: 7522627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis.
    Langrehr JM; Machens C; Zill E; Leder K; Nüssler A; Hoffman R; Neuhaus P
    Transplantation; 2000 Jun; 69(11):2415-21. PubMed ID: 10868651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous nitric oxide protects against T cell-dependent lethality during graft-versus-host disease and idiopathic pneumonia syndrome.
    Hongo D; Bryson JS; Kaplan AM; Cohen DA
    J Immunol; 2004 Aug; 173(3):1744-56. PubMed ID: 15265904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional changes of intestinal intraepithelial lymphocytes during acute graft versus host disease: correlation with phenotype.
    Nussler NC; Hoffman RA; McCarthy SA; Simmons RL
    Int Immunol; 1996 Nov; 8(11):1767-77. PubMed ID: 8943572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
    Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
    Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.
    Pandey R; Hegde VL; Nagarkatti M; Nagarkatti PS
    J Pharmacol Exp Ther; 2011 Sep; 338(3):819-28. PubMed ID: 21673072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice.
    Ellison CA; Natuik SA; McIntosh AR; Scully SA; Danilenko DM; Gartner JG
    Immunology; 2003 Jul; 109(3):440-9. PubMed ID: 12807491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
    Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
    J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
    Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
    Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease.
    Hoffman RA; Langrehr JM; Wren SM; Dull KE; Ildstad ST; McCarthy SA; Simmons RL
    J Immunol; 1993 Aug; 151(3):1508-18. PubMed ID: 8335943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).
    Azar Y; Shainer R; Almogi-Hazan O; Bringer R; Compton SR; Paidas MJ; Barnea ER; Or R
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):519-28. PubMed ID: 23266739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice.
    Jacobs P; Radzioch D; Stevenson MM
    J Immunol; 1995 Dec; 155(11):5306-13. PubMed ID: 7594544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease.
    Hartmann N; Leithäuser F; Albers C; Duyster J; Möller P; Debatin KM; Strauss G
    Leukemia; 2011 May; 25(5):848-55. PubMed ID: 21331071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.